Kim HK - Search Results

1

Hodgkin's disease in elderly patients (> or =60): clinical outcome and treatment strategies.

Kim HK, Silver B, Li S, Neuberg D, Mauch P. Kim HK, et al. Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):556-60. doi: 10.1016/s0360-3016(02)04596-0. Int J Radiat Oncol Biol Phys. 2003. PMID: 12738333

2

FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: a blinded comparison.

Friedberg JW, Fischman A, Neuberg D, Kim H, Takvorian T, Ng AK, Mauch PM, Canellos GP, van den Abbeele AD. Friedberg JW, et al. Leuk Lymphoma. 2004 Jan;45(1):85-92. doi: 10.1080/1042819031000149430. Leuk Lymphoma. 2004. PMID: 15061202 Clinical Trial.

3

Autologous bone marrow transplantation for marginal zone non-Hodgkin's lymphoma.

Brown JR, Gaudet G, Friedberg JW, Neuberg D, Mauch P, Kutok JL, Takvorian T, Fisher DC, Gribben JG, Kim H, Nadler LM, Freedman AS. Brown JR, et al. Leuk Lymphoma. 2004 Feb;45(2):315-20. doi: 10.1080/10428190310001593157. Leuk Lymphoma. 2004. PMID: 15101717

4

Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma.

Brown JR, Yeckes H, Friedberg JW, Neuberg D, Kim H, Nadler LM, Freedman AS. Brown JR, et al. J Clin Oncol. 2005 Apr 1;23(10):2208-14. doi: 10.1200/JCO.2005.05.158. Epub 2005 Mar 7. J Clin Oncol. 2005. PMID: 15753460

5

Effective purging of autologous hematopoietic stem cells using anti-B-cell monoclonal antibody-coated high-density microparticles prior to high-dose therapy for patients with non-Hodgkin's lymphoma.

Webb IJ, Friedberg nW, Gribben JG, Fisher DC, Spitzer T, Neuberg D, Jallow H, Kim H, Houde H, Monroy R, Schmittling R, Freedman AS. Webb IJ, et al. Biol Blood Marrow Transplant. 2002;8(8):429-34. doi: 10.1053/bbmt.2002.v8.pm12234168. Biol Blood Marrow Transplant. 2002. PMID: 12234168 Free article. Clinical Trial.

6

Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease: unacceptable acute pulmonary toxicity.

Friedberg JW, Neuberg D, Kim H, Miyata S, McCauley M, Fisher DC, Takvorian T, Canellos GP. Friedberg JW, et al. Cancer. 2003 Sep 1;98(5):978-82. doi: 10.1002/cncr.11582. Cancer. 2003. PMID: 12942565 Free article. Clinical Trial.

7

Oral fludarabine has significant activity in patients with previously untreated chronic lymphocytic leukemia, and leads to increased STAT1 levels in vivo.

Friedberg JW, Dong DA, Li S, Kim H, Stephans K, Noonan K, Neuberg D, Gribben JG, Fisher DC, Freedman AS, Takvorian T, Jurgens R, Battle TE, Frank DA. Friedberg JW, et al. Leuk Res. 2004 Feb;28(2):139-47. doi: 10.1016/s0145-2126(03)00213-3. Leuk Res. 2004. PMID: 14654078 Clinical Trial.

8

Combination immunotherapy with a CpG oligonucleotide (1018 ISS) and rituximab in patients with non-Hodgkin lymphoma: increased interferon-alpha/beta-inducible gene expression, without significant toxicity.

Friedberg JW, Kim H, McCauley M, Hessel EM, Sims P, Fisher DC, Nadler LM, Coffman RL, Freedman AS. Friedberg JW, et al. Blood. 2005 Jan 15;105(2):489-95. doi: 10.1182/blood-2004-06-2156. Epub 2004 Sep 9. Blood. 2005. PMID: 15358617 Free article. Clinical Trial.

9

Clinical efficacy of 0.1% cyclosporine A in dry eye patients with inadequate responses to 0.05% cyclosporine A: a switching, prospective, open-label, multicenter study.

Yoon SH, Kim EC, You IC, Choi CY, Kim JY, Song JS, Hyon JY, Kim HK, Seo KY. Yoon SH, et al. Among authors: kim hk. BMC Ophthalmol. 2025 Jan 22;25(1):37. doi: 10.1186/s12886-025-03862-x. BMC Ophthalmol. 2025. PMID: 39844141 Free article.

10

Association of pre-surgical circulating tumor DNA detection, use of sublobar resection with risk of recurrence in stage I non-small cell lung cancer.

Hong TH, Hwang S, Abbosh C, Dasgupta A, Jeon YJ, Lee J, Park SY, Cho JH, Choi YS, Shim YM, Hung T, Bredno J, Hodgson D, Ahn MJ, Kim HK. Hong TH, et al. Among authors: kim hk. Eur J Cancer. 2025 Jan 13;217:115237. doi: 10.1016/j.ejca.2025.115237. Online ahead of print. Eur J Cancer. 2025. PMID: 39826198

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,017 results

Search Page

Filters